Free Trial

12,466 Shares in Concentrix Co. (NASDAQ:CNXC) Bought by American Century Companies Inc.

Concentrix logo with Business Services background

American Century Companies Inc. purchased a new position in shares of Concentrix Co. (NASDAQ:CNXC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,466 shares of the company's stock, valued at approximately $539,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CNXC. Stifel Financial Corp raised its stake in shares of Concentrix by 9.0% in the 3rd quarter. Stifel Financial Corp now owns 36,131 shares of the company's stock valued at $1,852,000 after purchasing an additional 2,997 shares during the period. State Street Corp boosted its holdings in shares of Concentrix by 1.3% during the 3rd quarter. State Street Corp now owns 1,401,953 shares of the company's stock valued at $71,850,000 after acquiring an additional 18,304 shares in the last quarter. Barclays PLC raised its position in Concentrix by 134.3% in the third quarter. Barclays PLC now owns 35,862 shares of the company's stock valued at $1,837,000 after purchasing an additional 20,559 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Concentrix by 5.2% during the third quarter. Geode Capital Management LLC now owns 878,092 shares of the company's stock worth $45,013,000 after purchasing an additional 43,295 shares during the last quarter. Finally, Franklin Resources Inc. bought a new position in Concentrix in the 3rd quarter valued at approximately $445,000. 90.34% of the stock is owned by institutional investors and hedge funds.

Concentrix Trading Down 0.6 %

Shares of CNXC stock traded down $0.30 during trading hours on Thursday, hitting $47.15. 100,301 shares of the company were exchanged, compared to its average volume of 944,945. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.42 and a current ratio of 1.42. Concentrix Co. has a fifty-two week low of $36.28 and a fifty-two week high of $77.00. The company has a 50 day simple moving average of $47.56 and a two-hundred day simple moving average of $46.42. The firm has a market cap of $3.01 billion, a P/E ratio of 12.71, a P/E/G ratio of 0.63 and a beta of 0.51.

Concentrix (NASDAQ:CNXC - Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported $2.79 earnings per share for the quarter, beating the consensus estimate of $2.58 by $0.21. The firm had revenue of $2.37 billion during the quarter, compared to the consensus estimate of $2.37 billion. Concentrix had a net margin of 2.61% and a return on equity of 16.67%. The business's revenue was down 1.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.57 earnings per share. Equities analysts anticipate that Concentrix Co. will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 6th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.3328 per share. The ex-dividend date is Friday, April 25th. This represents a $1.33 annualized dividend and a dividend yield of 2.82%. Concentrix's dividend payout ratio is 33.33%.

Insider Transactions at Concentrix

In other Concentrix news, Director Kathryn Hayley purchased 500 shares of the firm's stock in a transaction on Wednesday, January 22nd. The stock was acquired at an average price of $50.22 per share, for a total transaction of $25,110.00. Following the purchase, the director now owns 3,034 shares of the company's stock, valued at $152,367.48. This trade represents a 19.73 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 3.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

CNXC has been the subject of several recent research reports. Barrington Research decreased their price target on shares of Concentrix from $70.00 to $54.00 and set an "outperform" rating for the company in a research report on Monday, March 24th. Canaccord Genuity Group decreased their price target on Concentrix from $100.00 to $80.00 and set a "buy" rating for the company in a research note on Thursday, January 16th. Finally, Bank of America lifted their price objective on Concentrix from $58.00 to $59.00 and gave the stock a "neutral" rating in a research note on Thursday, March 27th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $69.60.

Read Our Latest Analysis on CNXC

About Concentrix

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Further Reading

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines